Sinularin markedly suppresses cell growth and induces apoptosis, as well as activate MAPKs and repress PI3K/AKT pathways, which are dependent on ROS generation, thereby exerting anti‐tumor effects against human renal cancer cells.59 This evidence concerns the gene AKT1 and neoplasm.